China
· Delayed Price · Currency is CNY Jiangsu Nhwa Pharmaceutical Co., LTD Statistics
Total Valuation
Jiangsu Nhwa Pharmaceutical Co., LTD has a market cap or net worth of CNY 27.38 billion. The enterprise value is 23.97 billion.
| Market Cap | 27.38B |
| Enterprise Value | 23.97B |
Important Dates
The next estimated earnings date is Friday, October 25, 2024.
| Earnings Date | Oct 25, 2024 |
| Ex-Dividend Date | May 15, 2024 |
Share Statistics
Jiangsu Nhwa Pharmaceutical Co., LTD has 1.02 billion shares outstanding. The number of shares has increased by 0.17% in one year.
| Shares Outstanding | 1.02B |
| Shares Change (YoY) | +0.17% |
| Shares Change (QoQ) | -1.16% |
| Owned by Insiders (%) | 17.72% |
| Owned by Institutions (%) | 17.10% |
| Float | 515.98M |
Valuation Ratios
The trailing PE ratio is 24.26 and the forward PE ratio is 20.26. Jiangsu Nhwa Pharmaceutical Co., LTD's PEG ratio is 1.27.
| PE Ratio | 24.26 |
| Forward PE | 20.26 |
| PS Ratio | 5.03 |
| PB Ratio | 4.03 |
| P/FCF Ratio | 36.40 |
| PEG Ratio | 1.27 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.80, with an EV/FCF ratio of 31.87.
| EV / Earnings | 21.38 |
| EV / Sales | 4.43 |
| EV / EBITDA | 17.80 |
| EV / EBIT | 20.41 |
| EV / FCF | 31.87 |
Financial Position
The company has a current ratio of 6.62, with a Debt / Equity ratio of 0.02.
| Current Ratio | 6.62 |
| Quick Ratio | 5.90 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.10 |
| Debt / FCF | 0.18 |
| Interest Coverage | 277.93 |
Financial Efficiency
Return on equity (ROE) is 17.66% and return on invested capital (ROIC) is 11.41%.
| Return on Equity (ROE) | 17.66% |
| Return on Assets (ROA) | 10.14% |
| Return on Capital (ROIC) | 11.41% |
| Revenue Per Employee | 1.00M |
| Profits Per Employee | 207,849 |
| Employee Count | 5,394 |
| Asset Turnover | 0.75 |
| Inventory Turnover | 2.43 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +11.60% in the last 52 weeks. The beta is 0.04, so Jiangsu Nhwa Pharmaceutical Co., LTD's price volatility has been lower than the market average.
| Beta (5Y) | 0.04 |
| 52-Week Price Change | +11.60% |
| 50-Day Moving Average | 25.63 |
| 200-Day Moving Average | 24.58 |
| Relative Strength Index (RSI) | 58.39 |
| Average Volume (20 Days) | 9,757,209 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Jiangsu Nhwa Pharmaceutical Co., LTD had revenue of CNY 5.40 billion and earned 1.12 billion in profits. Earnings per share was 1.11.
| Revenue | 5.40B |
| Gross Profit | 3.88B |
| Operating Income | 1.17B |
| Pretax Income | 1.27B |
| Net Income | 1.12B |
| EBITDA | 1.32B |
| EBIT | 1.17B |
| Earnings Per Share (EPS) | 1.11 |
Balance Sheet
The company has 3.52 billion in cash and 138.98 million in debt, giving a net cash position of 3.38 billion or 3.33 per share.
| Cash & Cash Equivalents | 3.52B |
| Total Debt | 138.98M |
| Net Cash | 3.38B |
| Net Cash Per Share | 3.33 |
| Equity (Book Value) | 6.71B |
| Book Value Per Share | 6.69 |
| Working Capital | 4.66B |
Cash Flow
In the last 12 months, operating cash flow was 1.18 billion and capital expenditures -432.34 million, giving a free cash flow of 752.05 million.
| Operating Cash Flow | 1.18B |
| Capital Expenditures | -432.34M |
| Free Cash Flow | 752.05M |
| FCF Per Share | 0.74 |
Margins
Gross margin is 71.73%, with operating and profit margins of 21.73% and 20.74%.
| Gross Margin | 71.73% |
| Operating Margin | 21.73% |
| Pretax Margin | 23.46% |
| Profit Margin | 20.74% |
| EBITDA Margin | 24.40% |
| EBIT Margin | 21.73% |
| FCF Margin | 13.92% |
Dividends & Yields
This stock pays an annual dividend of 0.32, which amounts to a dividend yield of 1.17%.
| Dividend Per Share | 0.32 |
| Dividend Yield | 1.17% |
| Dividend Growth (YoY) | 60.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 28.91% |
| Buyback Yield | -0.17% |
| Shareholder Yield | 1.00% |
| Earnings Yield | 4.12% |
| FCF Yield | 2.75% |
Stock Splits
The last stock split was on May 12, 2017. It was a forward split with a ratio of 1.6.
| Last Split Date | May 12, 2017 |
| Split Type | Forward |
| Split Ratio | 1.6 |
Scores
Jiangsu Nhwa Pharmaceutical Co., LTD has an Altman Z-Score of 19.34.
| Altman Z-Score | 19.34 |
| Piotroski F-Score | n/a |